{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:14:35Z","timestamp":1792620875175,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010355","name":"Hellenic Society of Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.esmoop.2021.100075","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T02:35:48Z","timestamp":1615430148000},"page":"100075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The DNA damage response network in the treatment of head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"6","author":[{"given":"A.","family":"Psyrri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gkotzamanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Papaxoinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Krikoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Economopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kotsantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.L.","family":"Souliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2021.100075_bib1","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/lary.27807","article-title":"Long term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status","volume":"129","author":"Du","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.esmoop.2021.100075_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fonc.2019.00827","article-title":"Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting","volume":"9","author":"Economopoulou","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cell.2017.01.002","article-title":"Endogenous DNA damage as a source of genomic instability in cancer","volume":"168","author":"Tubbs","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.esmoop.2021.100075_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geh025","article-title":"Endogenous DNA damage in humans: a review of quantitative data","volume":"19","author":"De Bont","year":"2004","journal-title":"Mutagenesis"},{"key":"10.1016\/j.esmoop.2021.100075_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.011","article-title":"The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where","volume":"154","author":"Pateras","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.esmoop.2021.100075_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.esmoop.2021.100075_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc.2015.4","article-title":"DNA repair, genome stability and cancer: a historical perspective","volume":"16","author":"Jeggo","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib8","doi-asserted-by":"crossref","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-016-0433-9","article-title":"Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword","volume":"35","author":"Visconti","year":"2016","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ajpath.2016.02.023","article-title":"Genomic and epigenomic alterations in cancer","volume":"186","author":"Chakravarthi","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.esmoop.2021.100075_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/2159-8290.CD-17-0226","article-title":"DNA damage and repair biomarkers of immunotherapy response","volume":"7","author":"Mouw","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.esmoop.2021.100075_bib13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.esmoop.2021.100075_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","article-title":"Mechanisms of resistance to cisplatin","volume":"478","author":"Kartalou","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.dnarep.2006.03.009","article-title":"Gamma-H2AX formation in response to interstrand crosslinks requires 7XPF in human cells","volume":"5","author":"Mogi","year":"2006","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.esmoop.2021.100075_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/carcin\/bgq064","article-title":"Homologous recombination in cancer development, treatment and development of drug resistance","volume":"31","author":"Helleday","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.esmoop.2021.100075_bib17","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1038\/ncomms13049","article-title":"Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes","volume":"7","author":"Chakraborty","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.esmoop.2021.100075_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919849753","article-title":"Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer","volume":"11","author":"Ledermann","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS\u2013cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.esmoop.2021.100075_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.esmoop.2021.100075_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS\u2013STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.esmoop.2021.100075_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS\u2013STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.esmoop.2021.100075_bib26","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","article-title":"Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","article-title":"A\u00a0decade of clinical development of PARP inhibitors in perspective","volume":"30","author":"Mateo","year":"2019","journal-title":"Ann Oncol"},{"issue":"suppl 7","key":"10.1016\/j.esmoop.2021.100075_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2019.37.7_suppl.145","article-title":"Keynote-365 cohort a: pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)","volume":"37","author":"Yu","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40425-018-0463-2","article-title":"Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations","volume":"6","author":"Karzai","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib30","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1200\/JCO.2016.72.1340","volume":"35","author":"Lee","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2018.04.555","article-title":"An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): results in germline BRCA-mutated (gBRCA m) platinum-sensitive relapsed (PSR) ovarian cancer (OC)","volume":"149","author":"Drew","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2021.100075_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2018.36.15_suppl.1011","article-title":"TOPACIO\/Keynote-162: niraparib\u00a0+ pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a Phase II trial","volume":"36","author":"Vinayak","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 5","key":"10.1016\/j.esmoop.2021.100075_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.2018.36.5_suppl.48","article-title":"A\u00a0Phase Ib study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors","volume":"36","author":"Friedlander","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2021.100075_bib34","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1200\/JCO.2019.37.15_suppl.2562","article-title":"Open-label, multicenter, phase I study to assess safety and tolerability of adavosertib plus durvalumab in patients with advanced solid tumors","volume":"37","author":"Patel","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib35","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2021.100075_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/bjc.2014.410","article-title":"Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma","volume":"111","author":"Gkotzamanidou","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib38","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1128\/MCB.25.18.8368-8378.2005","article-title":"Transcription-associated breaks in xerodermapigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome","volume":"25","author":"Theron","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1288\/00005537-198501000-00012","article-title":"An in\u00a0vivo model for squamous cell carcinoma of the head and neck","volume":"95","author":"Baker","year":"1985","journal-title":"Laryngoscope"},{"key":"10.1016\/j.esmoop.2021.100075_bib40","first-page":"1246","article-title":"Establishment, characterization, chemosensitivity, and radiosensitivity of two different cell lines derived from a human breast cancer biopsy","volume":"45","author":"Gioanni","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clim.2019.03.009","article-title":"DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis","volume":"203","author":"Souliotis","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.esmoop.2021.100075_bib42","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2016-01-691618","article-title":"DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7","volume":"128","author":"Gkotzamanidou","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.esmoop.2021.100075_bib43","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.esmoop.2021.100075_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13075-016-1081-3","article-title":"Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus","volume":"18","author":"Souliotis","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.esmoop.2021.100075_bib45","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.dnarep.2006.05.006","article-title":"Preferential in\u00a0vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure","volume":"5","author":"Souliotis","year":"2006","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.esmoop.2021.100075_bib46","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.3390\/ijms21010055","article-title":"DNA damage response and oxidative stress in systemic autoimmunity","volume":"21","author":"Souliotis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.esmoop.2021.100075_bib47","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/cr.2017.43","article-title":"Spontaneous DNA damage propels tumorigenicity","volume":"27","author":"Vitale","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0022-3859.180555","article-title":"Free radicals hasten head and neck cancer risk: a study of total oxidant, total antioxidant, DNA damage, and histological grade","volume":"62","author":"Singh","year":"2016","journal-title":"J\u00a0Postgrad Med"},{"key":"10.1016\/j.esmoop.2021.100075_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-387665-2.00006-7","article-title":"Oxidized base damage and single-strand break repair in mammalian genomes: role of disordered regions and posttranslational modifications in early enzymes","volume":"110","author":"Hegde","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.esmoop.2021.100075_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/OTT.S118980","article-title":"Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy","volume":"10","author":"Dequanter","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.esmoop.2021.100075_bib51","doi-asserted-by":"crossref","first-page":"a012609","DOI":"10.1101\/cshperspect.a012609","article-title":"Nucleotide excision repair in eukaryotes","volume":"5","author":"Sch\u00e4rer","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib52","doi-asserted-by":"crossref","first-page":"e0117654","DOI":"10.1371\/journal.pone.0117654","article-title":"Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer","volume":"10","author":"Stefanou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.esmoop.2021.100075_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mrfmmm.2011.08.002","article-title":"Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer","volume":"716","author":"Sliwinski","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12032-017-1057-4","article-title":"Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review","volume":"34","author":"Dylawerska","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dnarep.2012.01.003","article-title":"DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients","volume":"11","author":"Schena","year":"2012","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.esmoop.2021.100075_bib56","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1200\/JCO.2005.07.385","article-title":"Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome","volume":"23","author":"Dimopoulos","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib57","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2007-05-089193","article-title":"Dysfunctional homologous recombination mediates genomic instability and progression in myeloma","volume":"113","author":"Shammas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.esmoop.2021.100075_bib58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.yexmp.2010.08.005","article-title":"Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population","volume":"89","author":"Sliwinski","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.esmoop.2021.100075_bib59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12032-014-0067-8","article-title":"Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population","volume":"31","author":"Choudhury","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib60","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/cancers11050598","article-title":"Polymorphisms of mismatch repair pathway genes predict clinical outcomes in oral squamous cell carcinoma patients receiving adjuvant concurrent chemoradiotherapy","volume":"11","author":"Senghore","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2021.100075_bib61","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1007\/s13277-014-1792-5","article-title":"Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma","volume":"35","author":"Mahjabeen","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.esmoop.2021.100075_bib63","doi-asserted-by":"crossref","first-page":"150845","DOI":"10.1155\/2014\/150845","article-title":"Apoptosis and molecular targeting therapy in cancer","volume":"2014","author":"Hassan","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.esmoop.2021.100075_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-319-91442-8_15","article-title":"Olaparib","volume":"211","author":"Bochum","year":"2018","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.redox.2018.03.016","article-title":"Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer","volume":"17","author":"Hou","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.esmoop.2021.100075_bib66","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3892\/or.2013.2805","article-title":"DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer patients treated with platinum derivatives","volume":"31","author":"Fikrova","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.esmoop.2021.100075_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/mutage\/geq101","article-title":"Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives","volume":"26","author":"Burgaz","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.esmoop.2021.100075_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/gtmb.2010.0006","article-title":"Assessment of genetic damage in inflammatory, precancerous, and cancerous pathologies of the esophagus using the comet assay","volume":"14","author":"Vasavi","year":"2010","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.esmoop.2021.100075_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-009-0079-4","article-title":"Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women","volume":"10","author":"Santos","year":"2010","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.esmoop.2021.100075_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mrfmmm.2008.09.014","article-title":"Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients","volume":"648","author":"Synowiec","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.esmoop.2021.100075_bib72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jnci\/95.7.540","article-title":"Genetic instability in bladder cancer assessed by the comet assay","volume":"95","author":"Schabath","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.esmoop.2021.100075_bib73","doi-asserted-by":"crossref","first-page":"241.e15","DOI":"10.1016\/j.urolonc.2018.01.006","article-title":"The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer","volume":"36","author":"Allione","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib74","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/1471-2407-14-765","article-title":"DNA repair deficiency in peripheral blood lymphocytes of endometrial cancer patients with a family history of cancer","volume":"14","author":"Buchynska","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2016.11.018","article-title":"Apoptotic capacity and risk of squamous cell carcinoma of the head and neck","volume":"72","author":"Liu","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib76","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/ajco.13239","article-title":"Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?","volume":"16","author":"Raturi","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib77","first-page":"343","article-title":"Detection of hypoxia by measurement of DNA damage and repair in human lymphocytes (comet assay): a predictive variable for tumor response during chemotherapy in patients with head and neck squamous cell carcinoma","volume":"13","author":"Romanet","year":"1999","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.esmoop.2021.100075_bib78","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","article-title":"DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy","volume":"24","author":"Quintela-Fandino","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-8140(02)00167-6","article-title":"Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations","volume":"64","author":"Borgmann","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib80","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4149\/neo_2013_053","article-title":"Detection of DNA crosslinks in peripheral lymphocytes isolated from patients treated with platinum derivates using modified comet assay","volume":"60","author":"Fikrova","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.esmoop.2021.100075_bib81","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3390\/cancers12092517","article-title":"Monitoring DNA damage and repair in peripheral blood mononuclear cells of lung cancer radiotherapy patients","volume":"12","author":"Lobachevsky","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2021.100075_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.lungcan.2008.11.014","article-title":"Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients","volume":"65","author":"Suna","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.esmoop.2021.100075_bib83","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jjco\/hyq071","article-title":"Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients","volume":"40","author":"Zhou","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100075_bib84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI112335","article-title":"Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy","volume":"77","author":"Reed","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.esmoop.2021.100075_bib85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/1535-7163.MCT-19-0133","article-title":"Oxaliplatin-DNA adducts as predictive biomarkers of FOLFOX response in colorectal cancer: a potential treatment optimization strategy","volume":"19","author":"Zimmermann","year":"2020","journal-title":"Mol Cancer Ther"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:24:39Z","timestamp":1761855879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702921000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2059702921000314"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100075","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The DNA damage response network in the treatment of head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100075"}}